CLOTPROTECT THERAPEUTICS LIMITEDActive

Company number 15411618Private limited companyIncorporated 2024

Key figures

£53,374-71.0%
Net assets 2025/26
-71.0%
Average annual change 2024/25–2025/26
050 k100 k150 k200 k2024/252025/26

Like most small UK companies, CLOTPROTECT THERAPEUTICS LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2025/26
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
0200 k400 k600 k2024/252025/26
Filed accounts2024/25–2025/26
2024/252025/26
Cash at bank and in hand315,286154,967
Total assets431,205263,441
Total liabilities249,392210,067
Net assets / total equity184,30453,374
Average number of employees11

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Principal activity

Accounts 2026

The principal activity of the company during the year under review was Biotechnology.

As described in the company's latest filed accounts.

Summary: CLOTPROTECT THERAPEUTICS LIMITED

Company

CLOTPROTECT THERAPEUTICS LIMITED is a private limited company registered with Companies House under company number 15411618. It was incorporated on 15 Jan 2024. Its status is active. The registered office is in Leeds (LS2). Its nature of business (SIC 2007) is other research and experimental development on natural sciences and engineering (72190).

Accounts

The latest accounts in the database are for 2025/26 (period ending 31 Jan 2026); the company files small company accounts (filleted). Net assets were £53,374, down 71% on the previous year. Cash at bank and in hand was £154,967. Total assets were £263,441 and total liabilities £210,067. The company had an average of 1 employee. Figures are available for 2 financial years (2024/25–2025/26).

Control and charges

One person with significant control is registered.

Filing deadlines

The next accounts are due by 31 Oct 2026. The next confirmation statement is due by 28 Jan 2027.